Controversies in Pathology in Early-Stage Breast Cancer

Seminars in Radiation Oncology

Volumn 21, Issue 1, 2011, Pages 20-25

  Goldstein, S Neal ^a  

^a Advanced Diagnostics Laboratory   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ATYPICAL DUCTAL HYPERPLASIA; BREAST CANCER; BREAST HYPERPLASIA; BREAST SURGERY; CANCER RADIOTHERAPY; CANCER SURGERY; CLONAL VARIATION; DISEASE ASSOCIATION; HUMAN; INTRADUCTAL CARCINOMA; LYMPH VESSEL; PATHOLOGY; PRIORITY JOURNAL;

BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; HUMANS; MASTECTOMY, SEGMENTAL; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASM, RESIDUAL; PROGNOSIS;

EID: 78649852992     PISSN: 10534296     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semradonc.2010.08.003     Document Type: Article

References (66)

1. Veronesi U., Saccozzi R., Del V.M., et al. Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast. N Engl J Med 1981, 305:6-11.
2. Fisher B., Wolmark N., Fisher E.R., et al. Lumpectomy and axillary dissection for breast cancer: Surgical, pathological, and radiation considerations. World J Surg 1985, 9:692-698.
3. Fisher B., Bauer M., Margolese R., et al. Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med 1985, 312:665-673.
4. Meric F., Mirza N.Q., Vlastos G., et al. Positive surgical margins and ipsilateral breast tumor recurrence predict disease-specific survival after breast-conserving therapy. Cancer 2003, 97:926-933.
5. Mirza N.Q., Vlastos G., Meric F., et al. Predictors of locoregional recurrence among patients with early-stage breast cancer treated with breast-conserving therapy. Ann Surg Oncol 2002, 9:256-265.
6. Gage I., Schnitt S.J., Nixon A.J., et al. Pathologic margin involvement and the risk of recurrence in patients treated with breast-conserving therapy. Cancer 1996, 78:1921-1928.
7. Park C.C., Mitsumori M., Nixon A., et al. Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence. J Clin Oncol 2000, 18:1668-1675.
8. Wazer D.E., Jabro G., Ruthazer R., et al. Extent of margin positivity as a predictor for local recurrence after breast conserving irradiation. Radiol Oncol Investig 1999, 7:111-117.
9. Obedian E., Haffty B.G. Negative margin status improves local control in conservatively managed breast cancer patients. Cancer J Sci Am 2000, 6:28-33.
10. Freedman G., Fowble B., Hanlon A., et al. Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy. Int J Radiat Oncol Biol Phys 1999, 44:1005-1015.
11. Meijnen P., Oldenburg H.S., Peterse J.L., et al. Clinical outcome after selective treatment of patients diagnosed with ductal carcinoma in situ of the breast. Ann Surg Oncol 2008, 15:235-243.
12. Florentine B.D., Kaushal N.K., Puig M.R., et al. Breast-conservation treatment outcomes: A community hospital's experience. Breast J 2009, 15:76-84.
13. Goldstein N.S., Kestin L., Vicini F. Factors associated with ipsilateral breast failure and distant metastases in patients with invasive breast carcinoma treated with breast-conserving therapy. A clinicopathologic study of 607 neoplasms from 583 patients. Am J Clin Pathol 2003, 120:500-527.
14. Assersohn L., Powles T.J., Ashley S., et al. Local relapse in primary breast cancer patients with unexcised positive surgical margins after lumpectomy, radiotherapy and chemoendocrine therapy. Ann Oncol 1999, 10:1451-1455.
15. DiBiase S.J., Komarnicky L.T., Schwartz G.F., et al. The number of positive margins influences the outcome of women treated with breast preservation for early stage breast carcinoma. Cancer 1998, 82:2212-2220.
16. Klimberg V.S., Harms S., Korourian S. Assessing margin status. Surg Oncol 1999, 8:77-84.
17. Smitt M.C., Nowels K.W., Zdeblick M.J., et al. The importance of the lumpectomy surgical margin status in long-term results of breast conservation. Cancer 1995, 76:259-267.
18. Sabel M.S., Rogers K., Griffith K., et al. Residual disease after re-excision lumpectomy for close margins. J Surg Oncol 2009, 99:99-103.
19. Kestin L.L., Goldstein N.S., Lacerna M.D., et al. Factors associated with local recurrence of mammographically detected ductal carcinoma in situ in patients given breast-conserving therapy. Cancer 2000, 88:596-607.
20. Peterson M.E., Schultz D.J., Reynolds C., et al. Outcomes in breast cancer patients relative to margin status after treatment with breast-conserving surgery and radiation therapy: The University of Pennsylvania experience. Int J Radiat Oncol Biol Phys 1999, 43:1029-1035.
21. Schnitt S.J., Abner A., Gelman R., et al. The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast-conserving surgery and radiation therapy. Cancer 1994, 74:1746-1751.
22. Smitt M.C., Nowels K., Carlson R.W., et al. Predictors of reexcision findings and recurrence after breast conservation. Int J Radiat Oncol Biol Phys 2003, 57:979-985.
23. Solin L.J., Fowble B.L., Schultz D.J., et al. The significance of the pathology margins of the tumor excision on the outcome of patients treated with definitive irradiation for early stage breast cancer. Int J Radiat Oncol Biol Phys 1991, 21:279-287.
24. Touboul E., Buffat L., Belkacemi Y., et al. Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer. Int J Radiat Oncol Biol Phys 1999, 43:25-38.
25. Wazer D.E., Schmidt-Ullrich R.K., Ruthazer R., et al. Factors determining outcome for breast-conserving irradiation with margin-directed dose escalation to the tumor bed. Int J Radiat Oncol Biol Phys 1998, 40:851-858.
26. Hewes J.C., Imkampe A., Haji A., et al. Importance of routine cavity sampling in breast conservation surgery. Br J Surg 2009, 96:47-53.
27. Swanson G.P., Rynearson K., Symmonds R. Significance of margins of excision on breast cancer recurrence. Am J Clin Oncol 2002, 25:438-441.
28. Povoski S.P., Jimenez R.E., Wang W.P., et al. Standardized and reproducible methodology for the comprehensive and systematic assessment of surgical resection margins during breast-conserving surgery for invasive breast cancer. BMC Cancer 2009, 9:254.
29. Voguet L., Hebert T., Leveque J., et al. Patient age and positive margins are predictive factors of residual tumor on mastectomy specimen after conservative treatment for breast cancer. Breast 2009, 18:233-237.
30. Zavagno G., Goldin E., Mencarelli R., et al. Role of resection margins in patients treated with breast conservation surgery. Cancer 2008, 112:1923-1931.
31. Kotwall C., Ranson M., Stiles A., et al. Relationship between initial margin status for invasive breast cancer and residual carcinoma after re-excision. Am Surg 2007, 73:337-343.
32. Frazier T.G., Wong R.W., Rose D. Implications of accurate pathologic margins in the treatment of primary breast cancer. Arch Surg 1989, 124:37-38.
33. Harris E.E., Schultz D.J., Jones H.A., et al. Factors associated with residual disease on re-excision in patients with ductal carcinoma in situ of the breast. Cancer J 2003, 9:42-48.
34. Neuschatz A.C., DiPetrillo T., Steinhoff M., et al. The value of breast lumpectomy margin assessment as a predictor of residual tumor burden in ductal carcinoma in situ of the breast. Cancer 2002, 94:1917-1924.
35. Saarela A.O., Paloneva T.K., Rissanen T.J., et al. Determinants of positive histologic margins and residual tumor after lumpectomy for early breast cancer: A prospective study with special reference to touch preparation cytology. J Surg Oncol 1997, 66:248-253.
36. Wazer D.E., Schmidt-Ullrich R.K., Schmid C.H., et al. The value of breast lumpectomy margin assessment as a predictor of residual tumor burden. Int J Radiat Oncol Biol Phys 1997, 38:291-299.
37. Tengher-Barna I., Hequet D., Reboul-Marty J., et al. Prevalence and predictive factors for the detection of carcinoma in cavity margin performed at the time of breast lumpectomy. Mod Pathol 2009, 22:299-305.
38. Morrow M. Margins in breast-conserving therapy: Have we lost sight of the big picture?. Expert Rev Anticancer Ther 2008, 8:1193-1196.
39. Anderson S.J., Wapnir I., Dignam J.J., et al. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five national surgical adjuvant breast and bowel project protocols of node-negative breast cancer. J Clin Oncol 2009, 27:2466-2473.
40. Clarke M., Collins R., Darby S., et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival survival: An overview of the randomized trials. Lancet 2005, 366:2087-2106. Early Breast Trialists' Collaborative Group E.
41. Yildirim E. Locoregional recurrence in breast carcinoma patients. Eur J Surg Oncol 2009, 35:258-263.
42. Goldstein N.S., Kestin L., Vicini F. Intraductal carcinoma of the breast: Pathologic features associated with local recurrence in patients treated with breast-conserving therapy. Am J Surg Pathol 2000, 24:1058-1067.
43. Vicini F.A., Goldstein N.S., Pass H., et al. Use of pathologic factors to assist in establishing adequacy of excision before radiotherapy in patients treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 2004, 60:86-94.
44. Vicini F.A., Kestin L.L., Goldstein N.S. Defining the clinical target volume for patients with early-stage breast cancer treated with lumpectomy and accelerated partial breast irradiation: A pathologic analysis. Int J Radiat Oncol Biol Phys 2004, 60:722-730.
45. Caughran J.L., Vicini F.A., Kestin L.L., et al. Optimal use of Re-excision in patients diagnosed with early-stage breast cancer by excisional biopsy treated with breast-conserving therapy. Ann Surg Oncol 2009, 16:3020-3027.
46. Fourquet A., Campana F., Zafrani B., et al. Prognostic factors of breast recurrence in the conservative management of early breast cancer: A 25-year follow-up. Int J Radiat Oncol Biol Phys 1989, 17:719-725.
47. Boyages J., Recht A., Connolly J.L., et al. Early breast cancer: predictors of breast recurrence for patients treated with conservative surgery and radiation therapy. Radiother Oncol 1990, 19:29-41.
48. Vicini F.A., Recht A., Abner A., et al. Recurrence in the breast following conservative surgery and radiation therapy for early-stage breast cancer. J Natl Cancer Inst Monogr 1992, 11:33-39.
49. Boehm D.U., Lebrecht A., Maltaris T., et al. Influence of resection volume on locoregional recurrence of breast cancer after breast-conserving surgery. Anticancer Res 2008, 28:1207-1211.
50. Kunos C., Latson L., Overmoyer B., et al. Breast conservation surgery achieving > or = 2-mm tumor-free margins results in decreased local-regional recurrence rates. Breast J 2006, 12:28-36.
51. Lovrics P.J., Cornacchi S.D., Farrokhyar F., et al. The relationship between surgical factors and margin status after breast-conservation surgery for early stage breast cancer. Am J Surg 2009, 197:740-746.
52. Horst K.C., Smitt M.C., Goffinet D.R., et al. Predictors of local recurrence after breast-conservation therapy. Clin Breast Cancer 2005, 5:425-438.
53. Dupont W.D., Page D.L. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 1985, 312:146-151.
54. Page D.L., Dupont W.D., Rogers L.W., et al. Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer 1985, 55:2698-2708.
55. Page D.L., Rogers L.W. Combined histologic and cytologic criteria for the diagnosis of mammary atypical ductal hyperplasia. Hum Pathol 1992, 23:1095-1097.
56. Tavassoli F.A., Norris H.J. A comparison of the results of long-term follow-up for atypical intraductal hyperplasia and intraductal hyperplasia of the breast. Cancer 1990, 65:518-529.
57. Goldstein N.S., Lacerna M., Vicini F. Cancerization of lobules and atypical ductal hyperplasia adjacent to ductal carcinoma in situ of the breast. Am J Clin Pathol 1998, 110:357-367.
58. Lennington W.J., Jensen R.A., Dalton L.W., et al. Ductal carcinoma in situ of the breast. Heterogeneity of individual lesions. Cancer 1994, 73:118-124.
59. Houssami N., Ciatto S., Ellis I., et al. Underestimation of malignancy of breast core-needle biopsy: Concepts and precise overall and category-specific estimates. Cancer 2007, 109:487-495.
60. Arora S., Menes T.S., Moung C., et al. Atypical ductal hyperplasia at margin of breast biopsy-Is re-excision indicated?. Ann Surg Oncol 2008, 15:843-847.
61. Haffty B.G., Reiss M., Beinfield M., et al. Ipsilateral breast tumor recurrence as a predictor of distant disease: Implications for systemic therapy at the time of local relapse. J Clin Oncol 1996, 14:52-57.
62. Hameed O., Pfeifer J.D. Classifying "recurrent" breast cancer: lost heterozygosity found. Am J Clin Pathol 2005, 123:641-643.
63. Recht A., Silen W., Schnitt S.J., et al. Time-course of local recurrence following conservative surgery and radiotherapy for early stage breast cancer. Int J Radiat Oncol Biol Phys 1988, 15:255-261.
64. Goldstein N.S., Vicini F.A., Hunter S., et al. Molecular clonality determination of ipsilateral recurrence of invasive breast carcinomas after breast-conserving therapy: Comparison with clinical and biologic factors. Am J Clin Pathol 2005, 123:679-689.
65. McGrath S., Antonucci J., Goldstein N., et al. Long-term patterns of In-breast failure in patients with early stage breast cancer treated with breast-conserving therapy: A molecular based clonality evaluation. Am J Clin Oncol 2010, 33:17-22.
66. Vicini F.A., Antonucci J.V., Goldstein N., et al. The use of molecular assays to establish definitively the clonality of ipsilateral breast tumor recurrences and patterns of in-breast failure in patients with early-stage breast cancer treated with breast-conserving therapy. Cancer 2007, 109:1264-1272.